Guilin Sanjin Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002275.SZ

Guilin Sanjin Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2023: USD -60.25 M

Guilin Sanjin Pharmaceutical Co., Ltd. Dividends Paid is USD -60.25 M for the year ending December 31, 2023, a 21.37% change year over year. Dividends paid is cash paid to shareholders as a distribution of profits.

Guilin Sanjin Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2022 was USD -76.63 M, a -5.80% change year over year.
Guilin Sanjin Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2021 was USD -72.43 M, a -257.32% change year over year.
Guilin Sanjin Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2020 was USD -20.27 M, a 30.76% change year over year.
Guilin Sanjin Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2019 was USD -29.28 M, a 15.72% change year over year.

Key data

Date	Dividends Paid	Capital Expenditure	Other Financing Activities	Net Cash Used Provided By Financing Activities

Shenzhen Stock Exchange: 002275.SZ

Guilin Sanjin Pharmaceutical Co., Ltd.

CEO	Mr. Xun Zou
IPO Date	July 10, 2009
Location	China
Headquarters	No.1, Gold Star(Jinxing) Road
Employees	2,615
Sector	Healthcare
Industries Pharmaceuticals Cosmetics Frozen Foods Non-Alcoholic Beverages Personal Care Pet Food Soft Drinks & Sodas Tobacco

Description

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China. The company primarily offers Guilin watermelon frost and lozenge, and Sanjin tablets under the Chinese TCM brand; and Naomaitai capsules, etc. It also produces TCM preparations. The company was founded in 1967 and is headquartered in Guilin, China. Guilin Sanjin Pharmaceutical Co., Ltd. operates as a subsidiary of Guilin SanJin Group Co.,Ltd.

Key trends

Past 5 years